Antibacterial resistance

被引:50
作者
Jocelyn Y. Ang
Elias Ezike
Basim I. Asmar
机构
[1] Children’s Hospital of Michigan,Division of Infectious Diseases
[2] Detroit Medical Center,Department of Pediatrics School of Medicine
[3] Wayne State University,undefined
[4] Children’s Hospital of Michigan,undefined
关键词
Penicillinnonsusceptible S. pneumoniae; Methicillinresistant S. aureus (MRSA); Vancomycinresistantenterococci (VRE); Extended spectrum betalactamase (ESBL) producers;
D O I
10.1007/BF02724275
中图分类号
学科分类号
摘要
Resistance to antimicrobial agents, whicl was recognized more than 50 years, continues to be a major cause of increased morbidity, mortality and health care cost. Overuse of antibiotics is considered the major contributing factor; however, poor implementation of infection control measures, prolonged hospitalization, admission to intensive care units and the use of invasive procedures are other contributing factors. The authors review the epidemiology, mechanism of resistance, treatment options and prevention measures of infections caused multi-drug resistant S.pneumoniae, methicillin-resistantS. aureus (MRSA), macrolide-resistantS. pyogenes and vancomycin-resistant enterococci (VRE) in pediatric patients. Antibacterial resistance among Gram-negative organisms, including extended spectrum beta-lactamase (ESBL) producing enteric bacteria, and the management and prevention of infections caused by these organisms are also discussed.
引用
收藏
页码:229 / 239
页数:10
相关论文
共 161 条
[21]  
Gay K(2001) from the cerebrospinal fluid of a patient who developed recrudescent meningitis Med Clin North America 85 1-17
[22]  
Stephens DS(1999)Acute otitis media : management and surveillance in an era of pneumococcal resistance — a report from The Drug-resistant MMWR 20 707-710
[23]  
Sutcliffe J(1998) pneumoniae Therapeutic Working Group Jama 279 593-598
[24]  
Tait-Kamradt A(2003)Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis Emerg Infect Dis 9 169-175
[25]  
Wondrack L(2002)Antimicrobial resistance in staphylococci Pediatr Infect Dis J 21 910-916
[26]  
Johnston NJ(1999)Antibiotic Therapy. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics Clin Infect Dis 29 797-800
[27]  
de Azavedo J(2002)Four pediatric deaths from community-acquired methicillin-resistant Pediatr Infect Dis J 21 530-534
[28]  
Kellner JD(1999) Minnesota and North Dakota, 1997–1999 Pediatr Infect Dis J 18 993-1000
[29]  
Low De(2003)Communityacquired methicillin-resistant Clin Infect Dis 36 429-439
[30]  
Schreiber JR(2001) in children with no identified predisposing risk Emerg Infect Dis 7 327-332